Safely Prescribing Opioids With Nirmatrelvir/ Ritonavir - Case Report and Management Recommendations

被引：1

作者：

Admane, Sonal ^{[1
,2
]}

Clark, Matthew ^{[1
]}

Reddy, Akhila ^{[1
]}

Narayanan, Santhosshi ^{[1
]}

Bruera, Eduardo ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Div Palliat Integrat & Rehabil Med, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Palliat Rehabil & Integrat Med, Houston, TX 77030 USA

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2024年 / 67卷 / 01期

关键词：

Opioids; Nirmatrelvir/Ritonavir; drug-drug interaction; opioid metabolism; CYP; 3A-4; enzyme; DRUG-DRUG INTERACTIONS; METHADONE; IMPACT; PAIN; BUPRENORPHINE; MEDICATIONS; METABOLISM;

D O I：

10.1016/j.jpainsymman.2023.09.027

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

[No abstract available]

引用

页码：e99 / e104

页数：6

共 42 条

[21] Off-Label Medication Use in the Inpatient Palliative Care Unit [J].

Kwon, Jung Hye ;

Kim, Min Ji ;

Bruera, Sebastian ;

Park, Minjeong ;

Bruera, Eduardo ;

Hui, David .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2017, 54 (01) :46-54

[22]

Labroo RB, 1997, DRUG METAB DISPOS, V25, P1072

[23] Methadone-induced Torsade de pointes after stopping lopinavir-ritonavir [J].

Luethi, B. ;

Huttner, A. ;

Speck, R. F. ;

Mueller, N. J. .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (05) :367-369

[24] Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications [J].

Marzolini, Catia ;

Kuritzkes, Daniel R. ;

Marra, Fiona ;

Boyle, Alison ;

Gibbons, Sara ;

Flexner, Charles ;

Pozniak, Anton ;

Boffito, Marta ;

Waters, Laura ;

Burger, David ;

Back, David J. ;

Khoo, Saye .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (06) :1191-1200

[25] The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients [J].

McCance-Katz, EF ;

Rainey, PM ;

Friedland, G ;

Jatlow, P .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (04) :476-482

[26] Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir [J].

McCance-Katz, Elinore F. ;

Moody, David E. ;

Smith, Patrick F. ;

Morse, Gene D. ;

Friedland, Gerald ;

Pade, Patricia ;

Baker, Jennifer ;

Alvanzo, Anika ;

Jatlow, Peter ;

Rainey, Petrie M. .

CLINICAL INFECTIOUS DISEASES, 2006, 43 :S235-S246

[27] Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review [J].

McCance-Katz, Elinore F. ;

Sullivan, Lynn E. ;

Nallani, Srikanth .

AMERICAN JOURNAL ON ADDICTIONS, 2010, 19 (01) :4-16

[28] Pain, Mood, and Substance Abuse in HIV: Implications for Clinic Visit Utilization, Antiretroviral Therapy Adherence, and Virologic Failure [J].

Merlin, Jessica S. ;

Westfall, Andrew O. ;

Raper, James L. ;

Zinski, Anne ;

Norton, Wynne E. ;

Willig, James H. ;

Gross, Robert ;

Ritchie, Christine S. ;

Saag, Michael S. ;

Mugavero, Michael J. .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 61 (02) :164-170

[29]

National Institutes of Health (NIH), DRUG DRUG INTERACTIO

[30] Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir [J].

Nieminen, Tuija H. ;

Hagelberg, Nora M. ;

Saari, Teijo I. ;

Neuvonen, Mikko ;

Neuvonen, Pertti J. ;

Laine, Kari ;

Olkkola, Klaus T. .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (10) :977-985

← 1 2 3 4 5 →